Loss of Presynaptic Terminal Integrity in the Substantia Nigra in Early Parkinson's Disease
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Loss of Presynaptic Terminal Integrity in the Substantia Nigra in Early Parkinson's Disease
Authors
Keywords
-
Journal
MOVEMENT DISORDERS
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-08-07
DOI
10.1002/mds.28216
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Synaptic Changes in Parkinson Disease Assessed with in vivo Imaging
- (2020) David Matuskey et al. ANNALS OF NEUROLOGY
- EANM practice guideline/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes 1.0
- (2020) Silvia Morbelli et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Synaptic vesicle protein 2A as a potential biomarker in synaptopathies
- (2019) Kerstin Heurling et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- Spread of α-synuclein pathology through the brain connectome is modulated by selective vulnerability and predicted by network analysis
- (2019) Michael X. Henderson et al. NATURE NEUROSCIENCE
- Neuronal vulnerability in Parkinson disease: Should the focus be on axons and synaptic terminals?
- (2019) Yvette C. Wong et al. MOVEMENT DISORDERS
- Quantification and discriminative power of 18F-FE-PE2I PET in patients with Parkinson’s disease
- (2019) Aline Delva et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Nigrostriatal dopamine transporter availability in early Parkinson's disease
- (2018) Patrik Fazio et al. MOVEMENT DISORDERS
- Quantifying SV2A density and drug occupancy in the human brain using [11C]UCB-J PET imaging and subcortical white matter as reference tissue
- (2018) Michel Koole et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Dopamine transporter imaging with [18F]FE-PE2I PET and [123I]FP-CIT SPECT—a clinical comparison
- (2018) Susanna Jakobson Mo et al. EJNMMI Research
- Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial
- (2017) Dilan Athauda et al. LANCET
- 11 C-PE2I and 18 F-Dopa PET for assessing progression rate in Parkinson's: A longitudinal study
- (2017) Weihua Li et al. MOVEMENT DISORDERS
- Synaptic vesicle glycoprotein 2C (SV2C) modulates dopamine release and is disrupted in Parkinson disease
- (2017) Amy R. Dunn et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Parkinson disease
- (2017) Werner Poewe et al. Nature Reviews Disease Primers
- Like prions: the propagation of aggregated tau and α-synuclein in neurodegeneration
- (2016) Michel Goedert et al. BRAIN
- Review: Sporadic Parkinson's disease: development and distribution ofα-synuclein pathology
- (2016) K. Del Tredici et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Imaging synaptic density in the living human brain
- (2016) Sjoerd J. Finnema et al. Science Translational Medicine
- MDS clinical diagnostic criteria for Parkinson's disease
- (2015) Ronald B. Postuma et al. MOVEMENT DISORDERS
- Pathological alpha-synuclein propagates through neural networks
- (2014) Masami Masuda-Suzukake et al. Acta Neuropathologica Communications
- Lewy body extracts from Parkinson disease brains trigger α-synuclein pathology and neurodegeneration in mice and monkeys
- (2013) Ariadna Recasens et al. ANNALS OF NEUROLOGY
- Disease duration and the integrity of the nigrostriatal system in Parkinson’s disease
- (2013) Jeffrey H. Kordower et al. BRAIN
- Quantification of Dopamine Transporter in Human Brain Using PET with 18F-FE-PE2I
- (2012) T. Sasaki et al. JOURNAL OF NUCLEAR MEDICINE
- Whole-Brain Mapping of Direct Inputs to Midbrain Dopamine Neurons
- (2012) Mitsuko Watabe-Uchida et al. NEURON
- Impaired neurotransmission caused by overexpression of -synuclein in nigral dopamine neurons
- (2012) M. Lundblad et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pathological -Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice
- (2012) K. C. Luk et al. SCIENCE
- Longitudinal evolution of compensatory changes in striatal dopamine processing in Parkinson's disease
- (2011) Ramachandiran Nandhagopal et al. BRAIN
- Protein Quantification at the Single Vesicle Level Reveals That a Subset of Synaptic Vesicle Proteins Are Trafficked with High Precision
- (2011) S. A. Mutch et al. JOURNAL OF NEUROSCIENCE
- Exogenous α-Synuclein Fibrils Induce Lewy Body Pathology Leading to Synaptic Dysfunction and Neuron Death
- (2011) Laura A. Volpicelli-Daley et al. NEURON
- The synaptic pathology of α-synuclein aggregation in dementia with Lewy bodies, Parkinson’s disease and Parkinson’s disease dementia
- (2010) Walter J. Schulz-Schaeffer ACTA NEUROPATHOLOGICA
- Systematic review of levodopa dose equivalency reporting in Parkinson's disease
- (2010) Claire L. Tomlinson et al. MOVEMENT DISORDERS
- Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results
- (2008) Christopher G. Goetz et al. MOVEMENT DISORDERS
- Axonal -synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease
- (2007) S. Orimo et al. BRAIN
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started